Optimized preparation of poly d,l (lactic-glycolic) microspheres and nanoparticles for oral administration
- 1 September 1996
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 141 (1-2), 81-91
- https://doi.org/10.1016/0378-5173(96)04618-2
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Characterization, stability and in vivo targeting of liposomal formulations containing cyclosporinInternational Journal of Pharmaceutics, 1995
- Optimization of pharmaceutical formulations based on response-surface experimental designsInternational Journal of Pharmaceutics, 1993
- Formation and Characterization of Cyclosporine-Loaded NanoparticlesJournal of Pharmaceutical Sciences, 1993
- Reduced kallikrein excretion by liposome-encapsulated cyclosporin in the ratJournal of Pharmacy and Pharmacology, 1993
- Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer's patchesJournal of Controlled Release, 1990
- Joint effects of monomer and stabilizer concentrations on physico-chemical characteristics of poly(butyl 2-cyanoacrylate) nanoparticlesJournal of Microencapsulation, 1990
- Nanocapsule formation by interfacial polymer deposition following solvent displacementInternational Journal of Pharmaceutics, 1989
- Liposomal Formulation Eliminates Acute Toxicity and Pump Incompatibility of Parenteral CyclosporinePharmaceutical Research, 1989
- The Preparation and Evaluation of Drug-Containing Poly(dl-lactide) Microspheres Formed by the Solvent Evaporation MethodPharmaceutical Research, 1987
- Evaluation of carrier capacity and release characteristics for poly( butyl 2-cyanoacrylate) nanoparticlesInternational Journal of Pharmaceutics, 1986